How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency

How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency

Abstract Congenital factor XIII (FXIII) deficiency is an extremely rare bleeding disorder (RBD) with estimated prevalence of one per 2 million in the general population. The disorder causes different clinical manifestations such as intracranial hemorrhage (ICH), recurrent miscarriage, umbilical...

Full description

Bibliographic Details
Main Authors: Hojat Shahraki, Akbar Dorgalaleh, Majid Fathi, Shadi Tabibian, Shahram Teimourian, Hasan Mollanoori, Alireza Khiabani, Farhad Zaker
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-10-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Factor XIII deficiency, Intracranial hemorrhage, Founder effect, Genetic Markers
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1206

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1206

Similar Items